Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Enhanced Imaging System to Become a Game-Changer in the OR by Revolutionizing Surgical Vision

By HospiMedica International staff writers
Posted on 07 Dec 2022

Critical structure identification and tissue perfusion assessment are essential for patients to have the best possible chance of healing well without facing life-threatening or costly complications. More...

Now, an easy-to-adapt module that seamlessly attaches to today’s laparoscopic systems provides real-time, on-demand surgical insights integrated into standard monitors. By leveraging AR, AI, ML and sensing-based technologies, the platform enables surgeons to view critical physiological structures and functions that cannot be seen with the naked eye.

The ActivSight Intelligent Light from Activ Surgical (Boston, MA, USA) is the first and only modular form-factor with multimodal Advanced Visualization for minimally invasive surgery. With ActivSight, surgeons can access critical intraoperative visual data as AR overlays, helping to increase surgical outcomes and patient safety. Surgeons can “see” otherwise imperceptible tissue perfusion with ActivPerfusion Mode. ActivICG Mode allows surgeons to visualize ICG (Indocyanine Green) in critical structures, such as bile ducts, using familiar techniques.

Designed with ease of use in mind, surgeons are able to access ActivPerfusion Mode with the push of a button and instantaneously see blood flow. With the press of a button, surgeons can switch between multiple modes of advanced intraoperative visualization. Real-time data allows surgeons to quickly assess tissue perfusion and make important decisions. Designed to address the most serious, costly patient complications and be a routine part of surgical practice, ActivSight is engineered to work with existing laparoscopic and robotic systems. Activ Surgical received 501(k)-clearance for ActivSight by the U.S. Food and Drug Administration (FDA) in in 2021 and has now also received CE Mark approval.

“As an early clinical advisor in the development of ActivSight Intelligent Light, I have seen first-hand the benefits it can provide me and my fellow surgeons in operating rooms around the world,” said Nicole Bouvy, surgeon and professor at Maastricht University Medical Center (MUMC+), The Netherlands. “The system is seamless to use and allows for advanced visualization during surgery, which makes it an important additional tool to potentially reduce surgical complications.”

“Patient safety is my number one priority in the operating room,” said Hans Fuchs, professor of surgery and head of robotic surgery for the department of surgery at the University of Cologne. “Activ Surgical is on the leading edge when it comes to enhancing surgical vision and significantly reducing unintended medical errors, and I am confident that ActivSight will improve surgical outcomes.”

Related Links:
Activ Surgical 


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A smartphone application displays a glucose concentration that was measured using the new sensor (Photo courtesy of Chuchu Chen and Yonghao Fu)

Wearable Device for Diabetics Could Replace Continuous Glucose Monitoring Systems

Monitoring blood glucose is essential for people with diabetes to prevent complications and maintain long-term health. Current continuous glucose monitoring systems require needles inserted under the skin,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.